Ameriprise Financial Inc
NYSE:AMP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
372.06
574.01
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ameriprise Financial Inc
Wall Street
Price Targets
AMP Price Targets Summary
Ameriprise Financial Inc
According to Wall Street analysts, the average 1-year price target for
AMP
is 567.46 USD
with a low forecast of 419.15 USD and a high forecast of 685.65 USD.
AMP Last Price Targets
Ameriprise Financial Inc
The latest public price target was made on Oct 30, 2024 by
Michael Cyprys
from
Morgan Stanley
,
who expects
AMP
stock to
drop by 4%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Michael Cyprys
Morgan Stanley
|
509
USD
Downside 4% |
1 month ago
Oct 30, 2024
|
Ameriprise Financial (AMP) PT Raised to $509 at Morgan Stanley
StreetInsider
|
Alexander Blostein
Goldman Sachs
|
476
USD
Downside 10% |
2 months ago
Sep 25, 2024
|
Goldman downgrades Ameriprise to Neutral after year-to-date rally
TheFly
|
Kenneth Lee
RBC Capital
|
500
USD
Downside 6% |
4 months ago
Jul 30, 2024
|
Ameriprise Financial (AMP) PT Raised to $500 at RBC Capital
StreetInsider
|
Brennan Hawken
UBS
|
495
USD
Downside 7% |
5 months ago
Jul 9, 2024
|
Ameriprise price target lowered to $495 from $500 at UBS
TheFly
|
Kevin Heal
Argus Research
|
460
USD
Downside 13% |
7 months ago
May 6, 2024
|
Ameriprise Financial (AMP) PT Raised to $460 at Argus
StreetInsider
|
|
Michael Cyprys
Morgan Stanley
|
445
USD
Downside 16% |
7 months ago
Apr 24, 2024
|
Ameriprise Financial (AMP) PT Raised to $445 at Morgan Stanley
StreetInsider
|
|
Michael Cyprys
Morgan Stanley
|
437
USD
Downside 17% |
8 months ago
Apr 9, 2024
|
Ameriprise price target raised to $437 from $400 at Morgan Stanley
TheFly
|
John Barnidge
Piper Sandler
|
392
USD
Downside 26% |
8 months ago
Apr 5, 2024
|
Ameriprise Financial (AMP) PT Raised to $392 at Piper Sandler
StreetInsider
|
Operating Income
Forecast
Operating Income Estimate
Ameriprise Financial Inc
For the last 8 years the
compound annual growth rate for
Ameriprise Financial Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
5%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AMP's stock price target?
Price Target
567.46
USD
According to Wall Street analysts, the average 1-year price target for
AMP
is 567.46 USD
with a low forecast of 419.15 USD and a high forecast of 685.65 USD.
What is Ameriprise Financial Inc's Revenue forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
Ameriprise Financial Inc's revenue is
4%.
The projected
CAGR
for the next 4 years is
7%.
What is Ameriprise Financial Inc's Operating Income forecast?
Projected CAGR
5%
For the last 8 years the
compound annual growth rate for
Ameriprise Financial Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
5%.
What is Ameriprise Financial Inc's Net Income forecast?
Projected CAGR
15%
For the last 8 years the
compound annual growth rate for
Ameriprise Financial Inc's net income is
6%.
The projected
CAGR
for the next 4 years is
15%.
You don't have any saved screeners yet
